Sven Lingjaerde

General Partner at Vision Capital Administration LLC

Sven Lingjaerde

Sven Lingjaerde

General Partner at Vision Capital Administration LLC

Overview
Career Highlights

Endeavour Vision SA

RelSci Relationships

147

Number of Boards

5

Contact Data
Trying to get in touch with Sven Lingjaerde? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Sven Lingjaerde likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at OncoEthix SA

Relationship likelihood: Strong

Co-Founder at OncoEthix SA

Relationship likelihood: Strong

Co-Founder at Quid, Inc.

Relationship likelihood: Strong

Co-Founder at Quid, Inc.

Relationship likelihood: Strong

Co-Founder at Indigo Agriculture, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Axovan AG

Relationship likelihood: Strong

Executive Chairman at Rgenix, Inc.

Relationship likelihood: Strong

Chairman at CeQur SA

Relationship likelihood: Strong

Chief Medical Officer & Founder at OncoEthix SA

Relationship likelihood: Strong

General Partner at Atomico

Relationship likelihood: Strong

Paths to Sven Lingjaerde
Potential Connections via
Relationship Science
You
Sven Lingjaerde
General Partner at Vision Capital Administration LLC
Education

The University of Lausanne is a higher teaching and research institution composed of seven faculties where approximately 14,300 students and 3,000 researchers work and study. UNIL is focused on several academic disciplines, especially Medicine, Life Sciences, Geosciences, Environment, Business, Humanities and Social Sciences. An emphasis is placed on an interdisciplinary approach, with close cooperation between students, teaching staff, and professors.

Career History
Co-Founder
2000 - Current

EV develops a long-term investment strategy with their entrepreneurs. Their investment objective is to grow firms and to create a market leader in a new field. They focus on developing businesses active in industries including information technology, biotech, medtech and cleantech. They concentrate on various stages such as early to expansion-stage as well as spin-offs and restarts. Their geographic focus is pan-European. Specifically, their technology-sector investments are concentrated in Norway, Sweden, Finland, UK, Ireland, Germany, Switzerland, France, Italy and Portugal. Beyond these countries, they also consider taking a co-lead or a syndicate role. For their life sciences investments, they primarily target Switzerland, France and Germany.Four key investment criteria they consider before investment are hyper-growth market potential, world-class technology, capital efficiency and ambitious management team. EV's preferred role is to be lead investor or possibly co-lead. They also consider being syndicate partner on some occasions.EV's investment horizon is generally 10 years, with that timeframe extended for firms in hyper-growth stage. On average, their investments typically take five years to mature. The majority of their exits are through a listing in one of the main markets while many of the VC-backed firms are acquired.

General Partner
Current

Vision Capital Administration focuses on investments in leading European technology companies in the communications, semiconductor, software and Internet/e-Commerce-related areas. They look for companies which are experiencing or are about to experience aggressive growth, and in companies that have demonstrated a clear technological advantage and where there is a very clear global market for such technology

Investment Manager
1987 - 1995

Genevest's portfolio of investments has reached maturity. The firm primarily oversees exit operations through trade sales and IPOs. Their past investments focused on sectors such as IT, communications, materials science, medical technology and life sciences, primarily in Europe and selectively in the US and Israel.The firm typically holds minority stakes in syndication with other investors, and generally does not sit on the board of their portfolio companies.

Boards & Committees
Board Member
Current

Quid, Inc. is an artificial intelligence company, which engages in the development of data and information capturing software. Its solutions include agencies, enterprise, consulting, and healthcare. The company was founded by Robert Goodson, Sean William Joseph Gourley, and Charles Cholsoo Lho in 2008 and is headquartered in San Francisco, CA.

Board Member
Current

DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA.

Non-Executive Director
Current

Europe Unlimited SA provides critical business resources to technology entrepreneurs, corporations, investors and researchers. Its online tool allows customers to connect with investors and entrepreneurs. The company was founded by William Stevens in 1998 and is headquartered in Brussels, Belgium.

Events
Attendee
Switzerland
2009 EVCA Investors' Forum

Attendee
Berlin, Germany
2008 EVCA Venture Capital Forum

The EVCA Venture Capital Forum brings together venture capital investors, entrepreneurs, policymakers and institutional investors from across Europe and beyond. It is three days of thought-leadership and intensive networking with the players that matter.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Sven Lingjaerde. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Sven Lingjaerde's profile does not indicate a business or promotional relationship of any kind between RelSci and Sven Lingjaerde.